White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effects of Afamelanotide for Patients with Early Parkinson’s Disease

Not recruiting

2 1 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Afamelanotide
Study of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials

Not recruiting

3 1 1 1
Investigated Drugs:
- Pertuzumab
- Trastuzumab
Study of ASP1570 Alone or with Pembrolizumab for Adults with Advanced Solid Tumors

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Asp1570
- Pembrolizumab
Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

Not recruiting

3 1 1
Investigated Diseases:
- Pulmonary embolism
Investigated Drugs:
- Alteplase
+2
Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

Not recruiting

2 1 1 1
Investigated Drugs:
Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

Not recruiting

1 1 1 1
Investigated Drugs:
- Selpercatinib
Study of trametinib and hydroxychloroquine in patients with metastatic pancreatic cancer that has not responded to previous treatment

Not recruiting

2 1 1 1
Investigated Drugs:
- Hydroxychloroquine Sulfate
- Trametinib
Study on Sotorasib for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with KRAS Mutation

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer stage III
Investigated Drugs:
- Sotorasib
Study on the Effectiveness of Paclitaxel, Docetaxel, and Oxaliplatin in Patients with Resectable Gastric Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Adenocarcinoma gastric
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies